These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 16011865)

  • 21. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of immunity by DNA vaccination: application to influenza and tuberculosis.
    Ulmer JB; Deck RR; DeWitt CM; Donnelly JJ; Friedman A; Montgomery DL; Yawman AM; Orme IM; Denis O; Content J; Huygen K; Liu MA
    Behring Inst Mitt; 1997 Feb; (98):79-86. PubMed ID: 9382773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys.
    Fan J; Liang X; Horton MS; Perry HC; Citron MP; Heidecker GJ; Fu TM; Joyce J; Przysiecki CT; Keller PM; Garsky VM; Ionescu R; Rippeon Y; Shi L; Chastain MA; Condra JH; Davies ME; Liao J; Emini EA; Shiver JW
    Vaccine; 2004 Aug; 22(23-24):2993-3003. PubMed ID: 15297047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines.
    Kodihalli S; Kobasa DL; Webster RG
    Vaccine; 2000 May; 18(23):2592-9. PubMed ID: 10775793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pandemic preparedness: toward a universal influenza vaccine.
    Roose K; Fiers W; Saelens X
    Drug News Perspect; 2009 Mar; 22(2):80-92. PubMed ID: 19330167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.
    Huleatt JW; Nakaar V; Desai P; Huang Y; Hewitt D; Jacobs A; Tang J; McDonald W; Song L; Evans RK; Umlauf S; Tussey L; Powell TJ
    Vaccine; 2008 Jan; 26(2):201-14. PubMed ID: 18063235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Broad cross-protection against H5N1 avian influenza virus infection by means of monoclonal antibodies that map to conserved viral epitopes.
    Chen Y; Qin K; Wu WL; Li G; Zhang J; Du H; Ng MH; Shih JW; Peiris JS; Guan Y; Chen H; Xia N
    J Infect Dis; 2009 Jan; 199(1):49-58. PubMed ID: 19032063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA vaccination with a single-plasmid construct coding for viruslike particles protects mice against infection with a highly pathogenic avian influenza A virus.
    Szécsi J; Gabriel G; Edfeldt G; Michelet M; Klenk HD; Cosset FL
    J Infect Dis; 2009 Jul; 200(2):181-90. PubMed ID: 19505256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.
    Tamura S; Tanimoto T; Kurata T
    Jpn J Infect Dis; 2005 Aug; 58(4):195-207. PubMed ID: 16116250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization.
    Fu TM; Friedman A; Ulmer JB; Liu MA; Donnelly JJ
    J Virol; 1997 Apr; 71(4):2715-21. PubMed ID: 9060624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virus.
    Ivanovska N; Tchorbanov A; Prechl J; Maximova V; Voynova E; Vassilev TL
    Vaccine; 2006 Mar; 24(11):1830-7. PubMed ID: 16289708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.
    Epstein SL; Tumpey TM; Misplon JA; Lo CY; Cooper LA; Subbarao K; Renshaw M; Sambhara S; Katz JM
    Emerg Infect Dis; 2002 Aug; 8(8):796-801. PubMed ID: 12141964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein.
    Chen Z; Yoshikawa T; Kadowaki SE; Hagiwara Y; Matsuo K; Asanuma H; Aizawa C; Kurata T; Tamura SI
    J Gen Virol; 1999 Oct; 80 ( Pt 10)():2559-2564. PubMed ID: 10573147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses.
    Holman DH; Wang D; Raja NU; Luo M; Moore KM; Woraratanadharm J; Mytle N; Dong JY
    Vaccine; 2008 May; 26(21):2627-39. PubMed ID: 18395306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.
    Wu R; Chen Q; Zheng L; Chen J; Sui Z; Guan Y; Chen Z
    Arch Virol; 2009; 154(8):1203-10. PubMed ID: 19543688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus.
    Wesley RD; Lager KM
    Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA immunization of newborn mice with a plasmid-expressing nucleoprotein of influenza virus.
    Bot A; Bot S; Garcia-Sastre A; Bona C
    Viral Immunol; 1996; 9(4):207-10. PubMed ID: 8978016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.